Alogliptin (13CD3) is a stable isotope-labeled active pharmaceutical ingredient, specifically a trideuteriomethyl and carbon-13 labeled derivative of the DPP-4 inhibitor alogliptin. It is primarily used as an analytical standard or internal standard in pharmaceutical research and manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Alogliptin (13CD3)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-Desmethyl,N-2(2-cyanobenzyl) Alogliptin
research compound
Pioglitazone D4
pharmaceutical raw material
2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-[(²H₃)methyloxy]-3,3-diphenylpropanoic acid
pharmaceutical raw material
8-Chloro-11-(1-nitrosopiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
pharmaceutical raw material
Eltrombopag Methyl Ester
pharmaceutical raw material
Eltrombopag Amide
pharmaceutical raw material
Meprednisone
pharmaceutical raw material
(S)-Alogliptin Benzoate Salt
pharmaceutical raw material
2-[[6-[(3R)-3-aminopiperidin-1-yl]-2,4-dioxo-3-(trideuterio(113C)methyl)pyrimidin-1-yl]methyl]benzonitrile
ZSBOMTDTBDDKMP-GKOPAMJVSA-N
[2H][13C]([2H])([2H])N1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N
Sourcing Alogliptin (13CD3)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.